now Vice President of the Board of Directors @ The Meadowbrook School
2010 -2013 VP Worldwide Regulatory Strategy, Specialty Care Business @
1999 -2010 VP Regulatory Affairs @
now Assistant Professor of Pharmacology and of Pathology @ University of Pennsylvania
1993 -1999 Vice President of the Board of Directors @ The Meadowbrook School
1981 -1985 Assistant Professor of Pharmacology and of Pathology @ University of Pennsylvania
now VP Regulatory Affairs @
Clare Kahn Education
The Royal Postgaduate Medical School, Hammersmith Hospital, Imperial College London
Doctor of Philosophy (Ph.D.) (Master of Science Biochemistry, Ph.D. clinical pharmacology)
1975-1981
Clare Kahn Skills
Vaccines
Regulatory Strategy
Regulatory Affairs
Clinical Development
Pharmaceutical Industry
Strategy
Clinical Trials
Biopharmaceuticals
Medical Affairs
Life Sciences
Oncology
Infectious Diseases
Regulatory Submissions
Drug Development
Clinical Research
GCP
Biotechnology
Immunology
Healthcare
FDA
Drug Discovery
Customer Service
Cross Functional Team Leadership
Pharmaceutics
Anti Infectives
Pharmacovigilance
Neurology
Microsoft Excel
Pharmaceutical Sales
Diabetes
Technology Transfer
Medical Writing
Sop
Therapeutic Areas
Rare Diseases
Pharmacology
Market Access
Cardiovascular Disease
Gender Health
CRO
Pain
Inflammation
Urology
Clare Kahn Summary
Clare Kahn, based in Philadelphia, PA, US, is currently a President and Owner at Clare Kahn Pharma Consulting LLC. Clare Kahn brings experience from previous roles at Stoke Therapeutics, Solid Biosciences, KBP BioSciences and X-VAX Technology Inc. Clare Kahn holds a 1975 - 1981 Doctor of Philosophy (Ph.D.) in Master of Science Biochemistry, Ph.D. clinical pharmacology @ The Royal Postgaduate Medical School, Hammersmith Hospital, Imperial College London. With a robust skill set that includes Vaccines, Regulatory Strategy, Regulatory Affairs, Clinical Development, Pharmaceutical Industry and more. Clare Kahn has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Clare Kahn?
Find contact details for 700 million professionals.